Article
Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipients
4 Oct 2022
Abstract excerpt
Allogeneic hematopoietic stem cell transplantation (HSCT) provides patients with severe hematologic disease a well-established potential for curation. Incorporation of germline analyses in the workup of HSCT patients is not a common practice. Recognizing rare harmful germline variants may however affect patients' pre-transplantation care, choice of the stem cell donor, and complication risks. We analyzed a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
